Health In Tech Beats Q1 Revenue Estimates, Secures $7M PIPE Funding
HIT has more than doubled off its 52-week low of $0.555.
Summary
Health In Tech reported Q1 revenue of $8.8M, significantly exceeding the Reuters estimate of $7.35M from earlier this week. The company also reiterated its full-year 2026 revenue guidance of $45M-$50M and announced the completion of a $7M PIPE financing in March 2026. The better-than-expected Q1 revenue could alleviate some investor concerns following the prior negative earnings expectation. The $7M PIPE represents a material capital infusion, providing funds for growth initiatives in sales, carriers, and technology, which is crucial for a company with continued net losses (Q1 net loss of $1.6M). Investors will monitor the company's ability to leverage the new capital to achieve its reiterated full-year guidance and move towards profitability.
At the time of this announcement, HIT was trading at $1.45 on NASDAQ in the Technology sector, with a market capitalization of approximately $87.9M. The 52-week trading range was $0.56 to $4.02. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Wiseek News.